ES2562789T3 - Supresión de la amplificación usando un oligonucleótido y una polimerasa que carece significativamente de actividad exonucleasa 5'-3' - Google Patents

Supresión de la amplificación usando un oligonucleótido y una polimerasa que carece significativamente de actividad exonucleasa 5'-3' Download PDF

Info

Publication number
ES2562789T3
ES2562789T3 ES08785392.5T ES08785392T ES2562789T3 ES 2562789 T3 ES2562789 T3 ES 2562789T3 ES 08785392 T ES08785392 T ES 08785392T ES 2562789 T3 ES2562789 T3 ES 2562789T3
Authority
ES
Spain
Prior art keywords
sequence
blocking oligonucleotide
oligonucleotide
target
target sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08785392.5T
Other languages
English (en)
Spanish (es)
Inventor
Nicolas Newton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2562789T3 publication Critical patent/ES2562789T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
ES08785392.5T 2007-08-08 2008-08-07 Supresión de la amplificación usando un oligonucleótido y una polimerasa que carece significativamente de actividad exonucleasa 5'-3' Active ES2562789T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96408907P 2007-08-08 2007-08-08
US964089P 2007-08-08
PCT/EP2008/006476 WO2009019008A1 (en) 2007-08-08 2008-08-07 Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5'-3' exonuclease activity

Publications (1)

Publication Number Publication Date
ES2562789T3 true ES2562789T3 (es) 2016-03-08

Family

ID=39942715

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08785392.5T Active ES2562789T3 (es) 2007-08-08 2008-08-07 Supresión de la amplificación usando un oligonucleótido y una polimerasa que carece significativamente de actividad exonucleasa 5'-3'

Country Status (7)

Country Link
US (1) US8071338B2 (enExample)
EP (1) EP2173910B1 (enExample)
JP (1) JP5524838B2 (enExample)
CN (1) CN101778952B (enExample)
CA (1) CA2693384C (enExample)
ES (1) ES2562789T3 (enExample)
WO (1) WO2009019008A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455190B2 (en) 2007-08-01 2013-06-04 Dana-Farber Cancer Institute, Inc. Enrichment of a target sequence
US8206929B2 (en) * 2009-01-07 2012-06-26 Roche Molecular Systems, Inc. Nucleic acid amplification with allele-specific suppression of sequence variants
JP6147502B2 (ja) * 2009-10-27 2017-06-14 スウィフト バイオサイエンシーズ， インコーポレイテッド ポリヌクレオチドプライマー及びプローブ
ES2665500T3 (es) * 2010-03-08 2018-04-26 Dana-Farber Cancer Institute, Inc. Enriquecimiento de una PCR por COLD completa con secuencia de bloqueo de referencia
US9944979B2 (en) * 2010-09-10 2018-04-17 Lsi Medience Corporation Inhibition method of nucleic acid amplification by photoirradiation and method of selective nucleic acid amplification with high sensitivity
JP5960709B2 (ja) 2010-10-27 2016-08-02 プレジデント アンド フェローズ オブ ハーバード カレッジ トーホールドプライマーデュプレックスの組成物およびその使用方法
US20120225421A1 (en) * 2011-02-28 2012-09-06 Transgenomic, Inc. Kit and method for sequencing a target dna in a mixed population
EP2691541B1 (en) * 2011-03-31 2017-10-18 Dana-Farber Cancer Institute, Inc. Method for enriching in single-stranded mutant sequences from mixture of wild-type and mutant sequences
WO2012151328A2 (en) 2011-05-02 2012-11-08 President And Fellows Of Harvard College Spatial sequestration of dynamic nucleic acid circuits
EP3382039B1 (en) * 2011-05-04 2023-09-13 Biocept, Inc. Methods for detecting nucleic acid sequence variants
US9518292B2 (en) 2011-05-26 2016-12-13 Brandeis University Methods for suppression PCR
WO2013009736A2 (en) 2011-07-10 2013-01-17 President And Fellows Of Harvard College Compositions and methods for self-assembly of polymers with complementary macroscopic and microscopic scale units
CA2848240C (en) 2011-09-16 2020-09-29 Lexogen Gmbh Nucleic acid transcription method
EP2570487A1 (en) 2011-09-16 2013-03-20 Lexogen GmbH Nucleic acid transcription method
US9260714B2 (en) * 2011-12-02 2016-02-16 Roche Molecular Systems, Inc. Suppression of non-specific amplification with high-homology oligonucleotides
US9133490B2 (en) 2012-05-16 2015-09-15 Transgenomic, Inc. Step-up method for COLD-PCR enrichment
CN105164280B (zh) * 2013-04-29 2017-09-26 凯杰马赛公司 使用阻断性寡核苷酸进行dna扩增的方法
HK1222209A1 (zh) * 2013-10-19 2017-06-23 Trovagene, Inc. 隨時間檢測疾病中的突變
WO2015179339A1 (en) * 2014-05-19 2015-11-26 William Marsh Rice University Allele-specific amplification using a composition of overlapping non-allele-specific primer and allele-specific blocker oligonucleotides
EP3198026B1 (en) * 2014-08-07 2019-10-09 Pharmassist Ltd Method of determining pik3ca mutational status in a sample
US12391985B2 (en) 2014-08-07 2025-08-19 Pharmassist Ltd Method of determining PIK3CA mutational status in a sample
UA122564C2 (uk) * 2014-09-26 2020-12-10 Янссен Фармацевтика Нв Використання панелі мутантних генів fgfr для ідентифікації пацієнтів із раковим захворюванням, які піддаються лікуванню інгібітором fgfr
US9909169B2 (en) * 2014-12-17 2018-03-06 Roche Molecular Systems, Inc. Allele-specific amplification of nucleic acids using blocking oligonucleotides for wild type suppression
JP5813263B1 (ja) * 2015-03-31 2015-11-17 日鉄住金環境株式会社 遺伝子変異の検出方法及びそれに用いる蛍光標識オリゴヌクレオチド
US9657353B2 (en) 2015-06-26 2017-05-23 Great Basin Scientific, Inc. Specific detection of organisms derived from a sample
WO2017193025A1 (en) 2016-05-06 2017-11-09 William Marsh Rice University Stoichiometric nucleic acid purification using randomer capture probe libraries
CN109477111B (zh) * 2016-06-07 2023-12-15 塞弗德公司 热稳定聚合酶抑制剂组合物和方法
US11371090B2 (en) 2016-12-12 2022-06-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection
US11174511B2 (en) 2017-07-24 2021-11-16 Dana-Farber Cancer Institute, Inc. Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture
WO2019099420A1 (en) * 2017-11-15 2019-05-23 Yan Wang A method for detecting multiple dna mutations and copy number variations
US12331350B2 (en) 2018-02-20 2025-06-17 William Marsh Rice University Systems and methods for allele enrichment using multiplexed blocker displacement amplification
AU2019307835B2 (en) 2018-07-19 2021-08-19 Biofidelity Ltd Improved polynucleotide sequence detection method
CN112654714B (zh) * 2018-12-17 2024-10-11 伊卢米纳剑桥有限公司 用于测序的引物寡核苷酸
GB201919186D0 (en) 2019-12-23 2020-02-05 Biofidelity Ltd Simplified polynucleotide sequence detection method
JP2024531713A (ja) * 2021-09-13 2024-08-29 ネクスジェン キャンサー ディテクション エルエルシー 試料中の標的ポリヌクレオチドを検出するための方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163393C (en) 1994-11-30 2003-04-22 Colleen Marie Nycz Amplification and detection of mycobacteria nucleic acids
US5801155A (en) * 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US5849497A (en) 1997-04-03 1998-12-15 The Research Foundation Of State University Of New York Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker
FR2779154B1 (fr) 1998-05-27 2002-07-12 Bio Merieux Procede d'amplification d'au moins une sequence nucleotidique particuliere et amorces de mise en oeuvre
AU780119B2 (en) * 1999-01-06 2005-03-03 Cornell Research Foundation Inc. Accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing
EP1253205A1 (en) 2001-04-24 2002-10-30 LION Bioscience AG Method of blocking amplification of selected sequences
GB0406863D0 (en) 2004-03-26 2004-04-28 Qiagen As Nucleic acid sequencing
DE602005022740D1 (de) 2004-09-10 2010-09-16 Human Genetic Signatures Pty Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn)

Also Published As

Publication number Publication date
WO2009019008A1 (en) 2009-02-12
HK1146094A1 (zh) 2011-05-13
CN101778952B (zh) 2016-05-25
JP5524838B2 (ja) 2014-06-18
US8071338B2 (en) 2011-12-06
EP2173910B1 (en) 2015-12-09
CA2693384A1 (en) 2009-02-12
EP2173910A1 (en) 2010-04-14
JP2010535480A (ja) 2010-11-25
US20090053720A1 (en) 2009-02-26
CA2693384C (en) 2015-04-14
CN101778952A (zh) 2010-07-14

Similar Documents

Publication Publication Date Title
ES2562789T3 (es) Supresión de la amplificación usando un oligonucleótido y una polimerasa que carece significativamente de actividad exonucleasa 5'-3'
ES2530273T3 (es) Amplificación de ácidos nucleicos específica de alelo
ES2608455T3 (es) Formato de sondas para detectar diferencias de ácidos nucleicos
ES2384681T3 (es) Extensión de cebadores correctora
ES2634428T3 (es) Amplificación de ácido nucleico con supresión específica de alelo de variantes de secuencia
EP1746172B1 (en) Asymmetric PCR coupled with post-PCR characterization for the identification of nucleic acids
ES2964624T3 (es) Detección de secuencias de ácidos nucleicos diana usando diferentes temperaturas de detección
ES2527653T3 (es) Amplificación específica de alelo usando un cebador con un nucleótido modificado
ES2414286T3 (es) Detección de ácidos nucleicos
AU2022294745B2 (en) Detection of multiple target nucleic acid using multiple detection temperatures
JP2015536685A (ja) 対立遺伝子特異的ｐｃｒにおける修飾されたリン酸及び修飾された塩基を有するプライマー
ES2656961T3 (es) Uso de G-Clamp para mejorar la PCR específica de alelo
ES2886605T3 (es) Procedimiento genérico para la estabilización de ARN específico
EP1606389B1 (en) Methods for polynucleotide sequence detection
US20160348158A1 (en) Format of Probes to Detect Nucleic Acid Differences
HK1146094B (en) Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5'-3' exonuclease activity